BCM
HGEN

Bayesian Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

Bayesian Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,400
Closed -$3K – 1097
2022
Q3 		$3K Buy
+18,400
New +$9.9K ﹤0.01% 659
2022
Q1 		– Sell
-10,200
Closed -$38K – 959
2021
Q4 		$38K Sell
10,200
-855
-8% -$5K 0.01% 356
2021
Q3 		$66K Buy
+11,055
New +$155K 0.02% 360

Other funds holding HGEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's HGEN Position: Q4 2022 in Review

Bayesian Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 18,400 shares — an estimated $3K sold.

Bayesian Capital Management first reported a position in HGEN in Q3 2021 and held it in 3 quarters. The position peaked at $66K in Q3 2021. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

  • Bayesian Capital Management reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 18,400 HUMANIGEN, INC. shares in Q4 2022, an estimated $3K.
  • Bayesian Capital Management first reported a position in HUMANIGEN, INC. in Q3 2021 and held it in 3 quarters.
  • Bayesian Capital Management's HUMANIGEN, INC. position peaked at $66K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.